Robocath

About:

Robocath is a medical robotics startup that partners with healthcare professionals to develop robotic solutions for vascular disease.

Website: https://www.robocath.com/

Twitter/X: robocath

Top Investors: European Investment Bank, Supernova Invest, GO CAPITAL, M Capital Partners, Normandie Incubation

Description:

Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions. R-One™ is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.

Total Funding Amount:

66.4M EUR

Headquarters Location:

Rouen, Haute-Normandie, France

Founded Date:

2009-01-01

Contact Email:

careers(AT)robocath.com

Founders:

Bruno Fournier, Philippe Bencteux

Number of Employees:

51-100

Last Funding Date:

2021-12-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai